Product News for July 2025
Discover groundbreaking FDA approvals for HIV prevention, targeted treatments, and OTC allergy relief, enhancing patient care and access to essential…
Evolving Business Models in Specialty and Infusion Pharmacy
Hospitals and health systems are adapting specialty and infusion pharmacy strategies to meet evolving payer mandates, rising costs, and shifting…
Meta-Analysis Suggests P2Y12 Inhibitor Is a Better Choice for Long-Term Single Antiplatelet Therapy
A meta-analysis suggests that long-term P2Y12 inhibitor monotherapy after percutaneous coronary intervention may offer superior protection against major adverse cardiac…
FDA Approves Sepiapterin for Adults, Children Living With Phenylketonuria
Sepiapterin treatment allowed for patients to liberalize their diet while reaching or exceeding recommended daily protein allowances in patients living…
EHA 2025: GOLCA Plus Rituximab Shows Promise in R/R DLBCL
Julio C. Chavez, MD, MS, discusses updated data from the European Hematology Association (EHA) 2025 Congress on the investigational oral…
FDA Expedites Durvalumab Review for Resectable Early-Stage Gastric, Gastroesophageal Cancers
Durvalumab continues to demonstrate efficacy in a variety of cancers, with new data from the phase 3 MATTERHORN trial solidifying…
Inconsistencies in Low-Density Lipoprotein Cholesterol Testing and Treatment After Revascularization
Patients with ASCVD face increased cardiovascular risks post-revascularization, yet many miss timely LDL-C testing and treatment, highlighting critical care gaps.
ENDO 2025: GLP-1 Receptor Agonists as Multisystem Therapies in Type 2 Diabetes Management
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses the expanding role of GLP-1 receptor agonists in holistic type 2 diabetes care,…
Lonapegsomatropin-Tcgd Receives FDA Approval for Growth Hormone Deficiency
FDA approves lonapegsomatropin for once-weekly treatment of growth hormone deficiency, offering a promising alternative for improved patient adherence and outcomes.
Fighting Financial Toxicity Through Oncology Drug Donation
George Wang discusses the widespread financial barriers cancer patients face, the environmental and economic toll of oncology drug waste, and…